Home › Marginal Zone Lymphoma › Minnesota › Rochester
Marginal Zone Lymphoma clinical trials in Rochester, MN
7 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Mayo Clinic - Rochester, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Mayo Clinic Rochester, Rochester
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
RecruitingObservational study
- Mayo Clinic, Rochester
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
RecruitingObservational study
- Mayo Clinic in Rochester, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
RecruitingPhase 1
- Mayo Clinic in Rochester, Rochester
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY10 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Columbus, OH8 studies
- Boston, MA8 studies
- Seattle, WA8 studies
- Edison, NJ8 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Denver, CO7 studies
- Nashville, TN7 studies
Other studies in Rochester
- Breast Cancer39 studies
- Non-Small Cell Lung Cancer38 studies
- Cancer (all types)31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer27 studies
- Colorectal Cancer27 studies
- Multiple Myeloma25 studies
- Heart Failure21 studies
- Lung Cancer21 studies
- Prostate Cancer20 studies
- Pancreatic Cancer20 studies
- Chronic Lymphocytic Leukemia20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.